01.11.2012 • NewsAcronfertilizerfertiliser

Russia's Acron Agrees $1.5 Billion Potash Project Financing

Russia's Acron, one of Europe's top 10 mineral fertilizer makers, has agreed $1.5 billion of equity and debt financing for a potash project in Russia, which could boost its output in four years.

Acron has attracted Russian state bank Vnesheconombank (VEB), Eurasian Development Bank and Raiffeisenbank to finance construction of its Talitsky mine in Russia's Urals region, which aims to start potash production in 2016, the company said on Thursday.

In a first stage, the three banks have acquired equity in Acron's firm which operates the project for 12.8 billion roubles ($408 million).

VEB bought 20% minus one share, Eurasian Development Bank received 9.1% and Raiffeisenbank received 8.95%. Acron owns the remaining share of the project.

These investments will allow full-scale construction of the Talitsky mine to start in the fourth quarter of 2012. The total capital expenditure required for the project is estimated at $2 billion, excluding the cost of the mining licence for the Talitsky area, which was about $700 million.

In the second part of the deal, VEB will provide debt financing in the form of a $1.1 billion credit line facility for further development of the project in 2014.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.